Article Sidebar
Published:
Jun 23, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
β-Elemene enhances cisplatin-induced apoptosis of nasopharyngeal carcinoma cells involving an endoplasmic reticulum stress pathway
Abstract
Purpose: To investigate whether β-elemene can enhance the anticancer activity of cisplatin in nasopharyngeal carcer (NPC) 5-8F cells and the possible molecular mechanism involved.
Methods: The cytotoxicity of β-elemene and its combination with cisplatin in 5-8F cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell cycle arrest was assessed by flow cytometry. Immunoblotting was performed to determine the expression levels of proteins related to the cell cycle (cyclin D1, p21, p27) and to cell apoptosis (Bax, cleaved caspase 9, Bcl-2, and cleaved caspase 3), as well as the endoplasmic reticulum (ER) stress pathway associated proteins.
Results: In 5-8F cells, β-elemene (40 μg/mL) and cisplatin (10 mM) exhibited synergistic effects on cell apoptosis and cell cycle arrest. The endoplasmic reticulum stress pathway-related proteins were significantly upregulated after the combination treatment of β-elemene and cisplatin (p < 0.05).
Conclusion: β-Elemene enhances the antitumor activity of cisplatin in 5-8F cells via a mechanism involving the endoplasmic reticulum stress pathway. Thus, β-elemene is a potential tumor-suppressive agent in the clinical management of nasopharyngeal carcinoma.
